The company also claimed that AstraZeneca and Alveofit are planning to expand this initiative to tier-2 and tier-3 towns across…
The drug, which generated sales of $214 million in 2021, belongs to a class of therapies called antibody drug conjugates.
In the last financial year, India’s pharma exports stood at around USD 24.62 billion with the US, the UK, South…
The FDA pointed to deficiencies in cleaning and maintenance of equipment to prevent contamination of drug products and also recommended…
Last year, Arunachal Pradesh partnered with the World Economic Forum’s ‘Medicines From the Sky’ (MFTS) initiative to integrate drones into…
The vaccine maker claims that BBV154 has the double benefit of enabling faster development of variant-specific vaccines and easy nasal…
No unexpected safety signals were observed and the findings from the trial will be presented at an upcoming medical meeting,…
Zantac, originally marketed by a forerunner of GSK, has been sold by several companies since the loss of patent exclusivity…
According to the company’s statement, the approval will enable them to market a generic equivalent of Antivert Tablets, 12.5 mg,…
Apollo Hospitals announces Q1 results; Registers over 35 percent drop in net profit to Rs. 317 crore
According to the Hospital group, in Q1FY23, the company’s total income stood at ₹3,811.66 crore compared to ₹3,784.85 crore in…
Xofluza is a single-dose oral medicine with a novel proposed mechanism of action that has demonstrated efficacy against a wide…
The drug was marketed by GSK between 1995 and 1998, by Pfizer from 2000 to 2006, by Johnson & Johnson…
Moreover, IOL’s PAT in Q1FY23 stood at Rs34.90 crore as compared to Rs27.80 crore in Q4FY22, registering a growth of…
It is unclear whether either approach will result in adequate protection against monkeypox, which is usually a mild to moderate…
Further development of the current or potential second-generation COVID-19 vaccine will depend on funding or commitments the group receives in…
Meanwhile, the revenue from operations declined to Rs 2,777 crore in the June quarter as compared with Rs 2,965 crore…
He will continue to serve in his current position until the identification, selection and transition to the new leadership takes…
According to the company, there have been 151 deals involving AI in the cardiovascular devices market since 2020.
